Jiangsu Nhwa Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 26.45%

Jiangsu Nhwa Pharmaceutical Co Ltd asset resilience ratio. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has an Asset Resilience Ratio of 26.45% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002262 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥2.52 Billion

≈ $369.05 Million USD Cash + Short-term Investments

Total Assets

CN¥9.54 Billion

≈ $1.40 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Jiangsu Nhwa Pharmaceutical Co Ltd (2016–2025)

Asset resilience ratio of Jiangsu Nhwa Pharmaceutical Co Ltd from 2016 to 2025. This chart shows how Jiangsu Nhwa Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Jiangsu Nhwa Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Nhwa Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Jiangsu Nhwa Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.52 Billion	26.45%
Total Liquid Assets	CN¥2.52 Billion	26.45%

Asset Resilience Insights

Very High Liquidity: Jiangsu Nhwa Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 26.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Nhwa Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Nhwa Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Jiangsu Nhwa Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2016–2025)

Jiangsu Nhwa Pharmaceutical Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Jiangsu Nhwa Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	27.85%	CN¥2.57 Billion ≈ $375.93 Million	CN¥9.22 Billion ≈ $1.35 Billion	-0.26pp
2024-12-31	28.12%	CN¥2.37 Billion ≈ $347.24 Million	CN¥8.44 Billion ≈ $1.24 Billion	+9.90pp
2023-12-31	18.22%	CN¥1.33 Billion ≈ $195.35 Million	CN¥7.33 Billion ≈ $1.07 Billion	-4.19pp
2022-12-31	22.40%	CN¥1.45 Billion ≈ $212.47 Million	CN¥6.48 Billion ≈ $948.40 Million	+3.83pp
2021-12-31	18.58%	CN¥1.06 Billion ≈ $154.88 Million	CN¥5.70 Billion ≈ $833.68 Million	+1.18pp
2020-12-31	17.39%	CN¥837.00 Million ≈ $122.48 Million	CN¥4.81 Billion ≈ $704.17 Million	+15.73pp
2019-12-31	1.67%	CN¥70.00 Million ≈ $10.24 Million	CN¥4.20 Billion ≈ $614.81 Million	-1.68pp
2018-12-31	3.35%	CN¥135.00 Million ≈ $19.75 Million	CN¥4.03 Billion ≈ $590.13 Million	-6.83pp
2017-12-31	10.18%	CN¥336.05 Million ≈ $49.17 Million	CN¥3.30 Billion ≈ $483.12 Million	+6.14pp
2016-12-31	4.03%	CN¥120.00 Million ≈ $17.56 Million	CN¥2.97 Billion ≈ $435.32 Million	--

pp = percentage points

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.38 Billion

CN¥23.07 Billion CNY

Market Cap Rank

#4464 Global

#658 in China

Share Price

CN¥22.77

Change (1 day)

+1.61%

52-Week Range

CN¥18.23 - CN¥25.64

All Time High

CN¥31.19